Patents by Inventor Helle Wittorff
Helle Wittorff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12257346Abstract: A powder mixture for oral delivery of active ingredients includes a population of particles and one or more active ingredients, the population of particles including at least two types of sugar alcohol particles. At least one of the at least two types of sugar alcohol particles takes the form of i) non-directly compressible (non-DC) sugar alcohol particles or ii) directly compressible (DC) sugar alcohol particles that are not granulated sugar alcohol particles. At least one of the at least two types of sugar alcohol particles has a particle size with more than 50% of the particles being below 250 microns, and at least one of the at least two types of sugar alcohol particles is present in an amount of at least 20% by weight of the powder mixture.Type: GrantFiled: April 30, 2021Date of Patent: March 25, 2025Assignee: Fertin Pharma A/SInventors: Helle Wittorff, Christine Nøhr Pedersen
-
Publication number: 20250009767Abstract: An adhesive oral disc for sustained release of cannabinoids is presented. The disc includes one or more cannabinoids and is composed of at least a mucosal contacting layer having a mucosal contacting surface operable to be fixed to the gingiva of a person in need of alleviation or treatment of a medical condition, where the mucosal contacting layer includes one or more mucoadhesive polymers allowing the adhesive oral disc to adhere to the gingiva for an extended period of time. Further, the disc includes a non-mucoadhesive module fused to the mucosal contacting layer, where the non-mucoadhesive module includes a solid tablet composition allowing the non-mucoadhesive module to dissolve within an extended period of time upon adhesion of the adhesive oral disc to the gingiva. The invention is particularly useful for alleviation or treatment of ulcers.Type: ApplicationFiled: July 8, 2024Publication date: January 9, 2025Applicant: Fertin Pharma A/SInventors: Helle Wittorff, Sanne Skov Jensen, Gitte Nykjær Nikolajsen, Gordon Findlay Dawson
-
Publication number: 20250009651Abstract: A dissolvable orally adhering nicotine tablet for sustained delivery of nicotine is disclosed, the tablet is a multilayer tablet comprising a first layer and a second layer, wherein the first layer is a mucoadhesive layer comprising a mucoadhesive, and wherein the second layer comprises at least one sugar alcohol and nicotine.Type: ApplicationFiled: July 8, 2024Publication date: January 9, 2025Inventors: Helle Wittorff, Bruno Provstgaard Nielsen, Helle Martinussen
-
Publication number: 20250009663Abstract: A mouthwash and method for oral care benefits includes a swishable powder delivery system having a content of at least two types of sugar alcohol particles with different particle size distributions and one or more active ingredients, the powder delivery system being a dry and flowable population of particles suitable for resembling a liquid mouthwash by swishing the powder delivery system, thereby generating fluid in the oral cavity without adding water.Type: ApplicationFiled: September 24, 2024Publication date: January 9, 2025Applicant: Fertin Pharma A/SInventors: Helle Wittorff, Christine Nøhr Pedersen
-
Publication number: 20250009732Abstract: A dissolvable orally adhering nicotine tablet for sustained delivery of nicotine is disclosed, the tablet is a multilayer tablet comprising a first layer and a second layer, wherein the first layer is a mucoadhesive layer comprising a mucoadhesive, nicotine, and at least one sugar alcohol, and wherein the second layer comprises at least one sugar alcohol.Type: ApplicationFiled: July 8, 2024Publication date: January 9, 2025Inventors: Helle Wittorff, Bruno Provstgaard Nielsen, Helle Martinussen
-
Publication number: 20250009650Abstract: A dissolvable orally adhering tablet for sustained release is disclosed, the tablet comprising an active ingredient, wherein the tablet is a multilayer tablet comprising a first layer and a second layer, the first layer being a mucoadhesive layer comprising a natural gum mucoadhesive and the second layer comprising at least one sugar alcohol.Type: ApplicationFiled: July 8, 2024Publication date: January 9, 2025Applicant: Fertin Pharma A/SInventor: Helle Wittorff
-
Publication number: 20240415775Abstract: An oral chewable tablet contains dextrose in an amount from 50 to 95% by weight of the tablet; and one or more active ingredients in an amount from 0.1 to 50% by weight of the tablet. The oral chewable tablet includes at least two compressed layers containing the dextrose and the one or more active ingredients, the first of the compressed layers being cohered to and adjacent to the second layer.Type: ApplicationFiled: October 12, 2022Publication date: December 19, 2024Applicant: Fertin Pharma A/SInventor: Helle Wittorff
-
Patent number: 12156943Abstract: The invention relates to a tablet dosage form for buccal absorption of active ingredients comprising a population of particles and an active ingredient to be released in the oral cavity for absorption through the oral mucosa, the population of particles comprising directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas.Type: GrantFiled: May 15, 2019Date of Patent: December 3, 2024Assignee: Fertin Pharma A/SInventor: Helle Wittorff
-
Patent number: 12128138Abstract: A mouthwash and method for oral care benefits includes a swishable powder delivery system having a content of at least two types of sugar alcohol particles with different particle size distributions and one or more active ingredients, the powder delivery system being a dry and flowable population of particles suitable for resembling a liquid mouthwash by swishing the powder delivery system, thereby generating fluid in the oral cavity without adding water.Type: GrantFiled: April 30, 2021Date of Patent: October 29, 2024Assignee: Fertin Pharma A/SInventors: Helle Wittorff, Christine Nøhr Pedersen
-
Patent number: 12109312Abstract: An oral tablet for taste masking of active ingredients includes a population of particles and an active ingredient with off-note taste. The population of particles includes directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting at least partly in induced taste masking of the active ingredient upon mastication of the tablet.Type: GrantFiled: June 8, 2021Date of Patent: October 8, 2024Assignee: Fertin Pharma A/SInventor: Helle Wittorff
-
Patent number: 12102714Abstract: A disintegrating oral tablet suitable for active pharmaceutical ingredients includes a population of particles and at least one flavor ingredient. The population of particles includes directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting in a burst of the at least one flavor ingredient upon mastication of the tablet.Type: GrantFiled: June 9, 2021Date of Patent: October 1, 2024Assignee: Fertin Pharma A/SInventor: Helle Wittorff
-
Patent number: 11903919Abstract: The present invention relates to an oral tablet for delivery of cannabinoids to mucosal surfaces comprising a population of particles and one or more cannabinoids, the population of particles comprising a) directly compressible (DC) sugar alcohol particles and b) non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas.Type: GrantFiled: February 18, 2021Date of Patent: February 20, 2024Assignee: NordicCan A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen, Helle Wittorff
-
Publication number: 20230123099Abstract: The invention relates to an oral chewable tablet suitable for improved mouthfeel, comprising dextrose in an amount from 50 to 95% by weight of the tablet; one or more active ingredients; and one or more binders, wherein the ratio between the one or more binders and dextrose is from 1:250 to 1:8.Type: ApplicationFiled: October 15, 2021Publication date: April 20, 2023Inventor: Helle WITTORFF
-
Patent number: 11484503Abstract: The invention relates to an oral delivery vehicle tablet, the delivery vehicle tablet being formed by compression of a plurality of particles, wherein the oral delivery vehicle tablet comprises sugar alcohol(s) in an amount of 40 to 99.9% by weight of the delivery vehicle tablet, wherein the oral delivery vehicle tablet comprises non-direct compressible (non-DC) erythritol particles in an amount of 15-50% by weight of the delivery vehicle tablet, wherein the oral delivery vehicle tablet comprises one or more binders other than binders granulated to the sugar alcohol(s) in an amount of 0.1 to 6% by weight of the tablet, wherein the delivery vehicle tablet comprises a plurality of further sugar alcohol particles in an amount of at least 10% by weight of the delivery vehicle tablet and wherein said further sugar alcohols particles have a composition which is different from said non-DC erythritol.Type: GrantFiled: November 13, 2019Date of Patent: November 1, 2022Assignee: FERTIN PHARMA A/SInventor: Helle Wittorff
-
Publication number: 20220331222Abstract: Provided are methods of providing at least one oral care benefit by introducing a tablet into the oral cavity to generate a fluid and forcing at least a portion of fluid generated around the oral cavity, for example, by swishing, rinsing, washing, etc., to provide an oral care benefit.Type: ApplicationFiled: May 31, 2022Publication date: October 20, 2022Inventors: Anthony R. Geonnotti, Patricia L. Golas, Helle Wittorff, Heidi Ziegler Bruun, Dorthe Shackinger Boesen
-
Patent number: 11351162Abstract: The invention relates an oral delivery vehicle tablet containing nicotine, the delivery vehicle tablet being formed by compression of a plurality of particles, the oral delivery vehicle tablet comprising nicotine, the oral delivery vehicle tablet comprising sugar alcohol(s) in an amount of 40 to 100% by weight of the delivery vehicle tablet, wherein at least 10% by weight of the delivery vehicle tablet comprises a plurality of particles consisting of erythritol and wherein the delivery vehicle tablet comprises a plurality of further sugar alcohol particles in an amount of at least 10% by weight of the delivery vehicle tablet, wherein said further sugar alcohol particles comprise at least one sugar alcohol and wherein said further sugar alcohols particles have a composition which is different from said particles consisting of erythritol.Type: GrantFiled: November 13, 2019Date of Patent: June 7, 2022Assignee: FERTIN PHARMA A/SInventors: Helle Wittorff, Heidi Ziegler Bruun, Dorthe Schackinger Boesen
-
Patent number: 11351103Abstract: Provided are methods of providing at least one oral care benefit by introducing a tablet into the oral cavity to generate a fluid and forcing at least a portion of fluid generated around the oral cavity, for example, by swishing, rinsing, washing, etc., to provide an oral care benefit.Type: GrantFiled: October 13, 2017Date of Patent: June 7, 2022Assignee: Johnson & Johnson Consumer Inc.Inventors: Anthony R. Geonnotti, Patricia L. Golas, Helle Wittorff, Heidi Ziegler Bruun, Dorthe Shackinger Boesen
-
Patent number: 11260030Abstract: An oral tablet for delivery of active ingredients to the gastrointestinal tract includes a population of particles and an active ingredient to be delivered to the gastrointestinal tract. The population of particles includes directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting in induced saliva generation upon mastication of the tablet, wherein the tablet is designed to be masticated and designed to deliver the active ingredient to the gastrointestinal tract as part of the saliva generated upon mastication of the tablet.Type: GrantFiled: June 10, 2021Date of Patent: March 1, 2022Assignee: Fertin Pharma A/SInventor: Helle Wittorff
-
Publication number: 20210346257Abstract: A powder mixture for oral delivery of active ingredients includes a population of particles and one or more active ingredients, the population of particles including at least two types of sugar alcohol particles. At least one of the at least two types of sugar alcohol particles takes the form of i) non-directly compressible (non-DC) sugar alcohol particles or ii) directly compressible (DC) sugar alcohol particles that are not granulated sugar alcohol particles. At least one of the at least two types of sugar alcohol particles has a particle size with more than 50% of the particles being below 250 microns, and at least one of the at least two types of sugar alcohol particles is present in an amount of at least 20% by weight of the powder mixture.Type: ApplicationFiled: April 30, 2021Publication date: November 11, 2021Applicant: Fertin Pharma A/SInventors: Helle Wittorff, Christine Nøhr Pedersen
-
Publication number: 20210346263Abstract: A mouthwash and method for oral care benefits includes a swishable powder delivery system having a content of at least two types of sugar alcohol particles with different particle size distributions and one or more active ingredients, the powder delivery system being a dry and flowable population of particles suitable for resembling a liquid mouthwash by swishing the powder delivery system, thereby generating fluid in the oral cavity without adding water.Type: ApplicationFiled: April 30, 2021Publication date: November 11, 2021Applicant: Fertin Pharma A/SInventors: Helle Wittorff, Christine Nøhr Pedersen